Form 4 for AGL agilon health, inc.
Accepted 2021-09-15 00:00:00 ET · period of report 2021-09-14 · accession 0001209191-21-056205 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-15 | 2021-09-14 | AGL | Sell Steven | CEO, Pres, Dir | M - OptEx | $4.50 | +100.0K | 100.0K | New | +$450.0K |
| D | 2021-09-15 | 2021-09-14 | AGL | Sell Steven | CEO, Pres, Dir | S - Sale+OE | $28.98 | -100.0K | 0 | -100% | -$2.90M |
| D | 2021-09-15 | 2021-09-14 | AGL | Sell Steven | CEO, Pres, Dir | M - OptEx | $0.00 | -100.0K | 900.0K | -10% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-14 | M | A | 100,000 | $4.50 | 100,000 | D | — | — | |
| 2 | Common | Common Stock | 2021-09-14 | S | D | 100,000 | $28.98 | 0 | D | — | — | |
| 3 | Derivative | Options (Rights to Buy) | 2021-09-14 | M | D | 100,000 | $0.00 | 900,000 | D | $4.50 · — to 2030-05-22 | 100,000 Common Stock | (F1) These options were granted on May 22, 2020, and fully vested on April 19, 2021. |